605 results on '"Brunnström, Hans"'
Search Results
2. The prognostic value of programmed death-ligand 1 (PD-L1) expression in resected colorectal cancer without neoadjuvant therapy - differences between antibody clones and cell types
3. 3D cultivation of non-small-cell lung cancer cell lines using four different methods
4. Publisher Correction: Shared heritability and functional enrichment across six solid cancers.
5. Shared heritability and functional enrichment across six solid cancers.
6. Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms
7. Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study
8. PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung
9. Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
10. The impact of different fixatives on immunostaining of lung adenocarcinomas in pleural effusion cell blocks.
11. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis
12. Supplementary Table 8 from Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
13. Supplementary Figure 2 from Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
14. Data from Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
15. Supplementary Table 9 from Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
16. Supplementary Table 4 from Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
17. Supplementary Figure 6 from Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
18. Supplementary Figure 4 from Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
19. Supplementary Table 5 from Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
20. Supplementary Figure Legends from Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
21. Supplementary Figure 5 from Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
22. Supplementary Table 6 from Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
23. Supplementary Table 7 from Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
24. Supplementary Figure 1 from Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
25. Supplementary Figure 7 from Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
26. Supplementary Table 3 from Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
27. Supplementary Table 1 from Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
28. Supplementary Table 2 from Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
29. Supplementary Figure 3 from Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
30. TGF-β-mediated epithelial–mesenchymal transition and tumor-promoting effects in CMT64 cells are reflected in the transcriptomic signature of human lung adenocarcinoma
31. Real-world analysis of MET exon 14 mutations in non-small cell lung cancer: a retrospective study from two Swedish hospitals
32. Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
33. Haem iron intake and risk of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
34. A new efficient method to detect genetic interactions for lung cancer GWAS
35. Protein-altering germline mutations implicate novel genes related to lung cancer development
36. Expression of cancer–testis antigens in the immune microenvironment of non‐small cell lung cancer
37. Treatment Refractory Arthritis and Stroke - A case of Infective Endocarditis caused by Tropheryma whipplei
38. Spatial immunophenotyping of the tumour microenvironment in non–small cell lung cancer
39. Abstract LB259: Distinct microRNA signature and suppression of ZFP36L1 define ASCL1-positive lung adenocarcinoma
40. Pulmonary 5-HT2B receptor expression in fibrotic interstitial lung diseases
41. Expression of cancer-testis antigens in the immune microenvironment of non-small cell lung cancer
42. Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer
43. Reference standards for gene fusion molecular assays on cytological samples: an international validation study
44. Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer
45. A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer
46. Supplementary Figure Legends from Genome-wide DNA Methylation Analysis of Lung Carcinoma Reveals One Neuroendocrine and Four Adenocarcinoma Epitypes Associated with Patient Outcome
47. Supplementary Methods from Genome-wide DNA Methylation Analysis of Lung Carcinoma Reveals One Neuroendocrine and Four Adenocarcinoma Epitypes Associated with Patient Outcome
48. Supplementary Figures 1-6 from Genome-wide DNA Methylation Analysis of Lung Carcinoma Reveals One Neuroendocrine and Four Adenocarcinoma Epitypes Associated with Patient Outcome
49. Aggrecan accumulates at sites of increased pulmonary arterial pressure in idiopathic pulmonary arterial hypertension
50. Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.